Early Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome
Early Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome
Not yet recruiting · NCT07799779 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Early Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome | Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Atherosclerotic, acute coronary syndrome, cardiovascular disorder, heart disorder, myocardial ischemia, vascular disorder | Not yet recruiting | Phase 4 | 2026-09-02 | NCT07799779 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dotter Co., Ltd. | 1 |
| Hanmi Pharmaceutical co., ltd. | 5 |
| Novartis Korea Ltd. | 1 |
| Seoul National University Bundang Hospital | 114 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Seoul National University Bundang Hospital | Seongnam-si | South Korea | 107 |